Dr. Sherine Abbas Helmy has 42 years of professional experience in the pharmaceutical industry. Throughout the years, he was appointed as CEO of Pharco Corporation, board member of Batterjee Pharmaceuticals, KSA; Pharco Impex, Romania; consultant of SEEG Pharm, Switzerland; and Presidio Pharmaceuticals, USA, CEO of Wealth & Resource Mining S.A.E, Board Member of BioGeneric Pharma S.A.E (BCP).
Dr.Sherine graduated in 1981 with a Bachelor of Science degree from the Faculty of Pharmacy, Alexandria University. He then obtained an MBA from the Arab Academy for Science and Technology (AAST) and Central Michigan University in 1999. In 2012, he received his Doctor of Business Administration degree from AAST, which was an additional step towards excelling in the business world.
He also attended Changing the Game: Negotiation & Competitive Decision-Making in November 2021 from Harvard Business School in Boston, USA.
He is a Board Member of several organizations, including The City Advisory Council Zewail City of Science and Technology. He is a member of the board of trustees of the Egyptian Japanese University for Science and Technology (EJUST) and, the Faculty of Pharmacy, Azhar University. He is a Member of the Strategic Advisory Board (SAB) of the American University in Cairo School of Business.
He is a Member of the Egyptian Lebanese, Egyptian Saudi, and Egyptian Senegalese Business Councils. He is also a member of the American Chamber of Commerce in Egypt (AMCHAM), the German-Arab Chamber of Industry and Commerce (AHK- MENA), the Swiss Egyptian Business Association (SEBA), and the French Chamber of Commerce and Industry in Egypt (CCIFE).